Critical Insights From Arcus Biosciences Analyst Ratings: What You Need To Know
Critical Insights From Arcus Biosciences Analyst Ratings: What You Need To Know
來自Arcus Biosciences分析師評級的關鍵見解：你需要知道的
Throughout the last three months, 4 analysts have evaluated Arcus Biosciences (NYSE:RCUS), offering a diverse set of opinions from bullish to bearish.
在過去的三個月中，有4位分析師對Arcus Biosciences（紐約證券交易所代碼：RCUS）進行了評估，提供了從看漲到看跌的不同觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估，說明了過去30天不斷變化的情緒，並將其與前幾個月進行了比較。
In the assessment of 12-month price targets, analysts unveil insights for Arcus Biosciences, presenting an average target of $34.5, a high estimate of $42.00, and a low estimate of $30.00. This current average represents a 20.69% decrease from the previous average price target of $43.50.
在對12個月目標股價的評估中，分析師公佈了對Arcus Biosciences的見解，平均目標股價爲34.5美元，最高估計爲42.00美元，低估值爲30.00美元。目前的平均價格比之前的平均目標價43.50美元下降了20.69％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級：詳細審查
The standing of Arcus Biosciences among financial experts becomes...
通過對分析師近期行...
登入免費觀看全文
登入/註冊